909 related articles for article (PubMed ID: 23442083)
21. Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix database.
Ganter B; Snyder RD; Halbert DN; Lee MD
Pharmacogenomics; 2006 Oct; 7(7):1025-44. PubMed ID: 17054413
[TBL] [Abstract][Full Text] [Related]
22. Metabolomics reviewed: a new "omics" platform technology for systems biology and implications for natural products research.
Rochfort S
J Nat Prod; 2005 Dec; 68(12):1813-20. PubMed ID: 16378385
[TBL] [Abstract][Full Text] [Related]
23. Identification of cellular MMP substrates using quantitative proteomics: isotope-coded affinity tags (ICAT) and isobaric tags for relative and absolute quantification (iTRAQ).
Butler GS; Dean RA; Morrison CJ; Overall CM
Methods Mol Biol; 2010; 622():451-70. PubMed ID: 20135298
[TBL] [Abstract][Full Text] [Related]
24. Where are we in genomics?
Hocquette JF
J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195
[TBL] [Abstract][Full Text] [Related]
25. Integration of 'omics' data: does it lead to new insights into host-microbe interactions?
Kint G; Fierro C; Marchal K; Vanderleyden J; De Keersmaecker SC
Future Microbiol; 2010 Feb; 5(2):313-28. PubMed ID: 20143952
[TBL] [Abstract][Full Text] [Related]
26. "Omics" in oral cancer: New approaches for biomarker discovery.
Rai V; Mukherjee R; Ghosh AK; Routray A; Chakraborty C
Arch Oral Biol; 2018 Mar; 87():15-34. PubMed ID: 29247855
[TBL] [Abstract][Full Text] [Related]
27. Community-acquired pneumonia: genomics, epigenomics, transcriptomics, proteomics, and metabolomics.
Waterer GW
Semin Respir Crit Care Med; 2012 Jun; 33(3):257-65. PubMed ID: 22718211
[TBL] [Abstract][Full Text] [Related]
28. On the road to systems biology of host-pathogen interactions.
Früh K; Finlay B; McFadden G
Future Microbiol; 2010 Feb; 5(2):131-3. PubMed ID: 20143936
[No Abstract] [Full Text] [Related]
29. Advances in Nutrigenomics research: novel and future analytical approaches to investigate the biological activity of natural compounds and food functions.
García-Cañas V; Simó C; León C; Cifuentes A
J Pharm Biomed Anal; 2010 Jan; 51(2):290-304. PubMed ID: 19467817
[TBL] [Abstract][Full Text] [Related]
30. Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology.
Heijne WH; Kienhuis AS; van Ommen B; Stierum RH; Groten JP
Expert Rev Proteomics; 2005 Oct; 2(5):767-80. PubMed ID: 16209655
[TBL] [Abstract][Full Text] [Related]
31. Metabolomics in pharmaceutical research and development: metabolites, mechanisms and pathways.
Xu EY; Schaefer WH; Xu Q
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):40-52. PubMed ID: 19152212
[TBL] [Abstract][Full Text] [Related]
32. Contribution of genomics to the understanding of physiological functions.
Hocquette JF; Cassar-Malek I; Scalbert A; Guillou F
J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():5-16. PubMed ID: 19996478
[TBL] [Abstract][Full Text] [Related]
33. The potential of metabolomics for Leishmania research in the post-genomics era.
Scheltema RA; Decuypere S; T'kindt R; Dujardin JC; Coombs GH; Breitling R
Parasitology; 2010 Aug; 137(9):1291-302. PubMed ID: 20109253
[TBL] [Abstract][Full Text] [Related]
34. Systems biology in critical-care nursing.
Schallom L; Thimmesch AR; Pierce JD
Dimens Crit Care Nurs; 2011; 30(1):1-7. PubMed ID: 21135603
[TBL] [Abstract][Full Text] [Related]
35. Evolving 'omics' technologies for diagnostics of head and neck cancer.
Nagaraj NS
Brief Funct Genomic Proteomic; 2009 Jan; 8(1):49-59. PubMed ID: 19273537
[TBL] [Abstract][Full Text] [Related]
36. Editorial: J. Basic Microbiol. 1/2009.
J Basic Microbiol; 2009 Feb; 49(1):3. PubMed ID: 19253329
[No Abstract] [Full Text] [Related]
37. The application of multi-omics and systems biology to identify therapeutic targets in chronic kidney disease.
Cisek K; Krochmal M; Klein J; Mischak H
Nephrol Dial Transplant; 2016 Dec; 31(12):2003-2011. PubMed ID: 26487673
[TBL] [Abstract][Full Text] [Related]
38. Recent progress in biomolecular engineering.
Ryu DD; Nam DH
Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
[TBL] [Abstract][Full Text] [Related]
39. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics.
Ferrer-Alcón M; Arteta D; Guerrero MJ; Fernandez-Orth D; Simón L; Martinez A
Toxicol Lett; 2009 Apr; 186(1):45-51. PubMed ID: 19022361
[TBL] [Abstract][Full Text] [Related]
40. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
Phan JH; Quo CF; Wang MD
Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
